GEN Exclusives

More »

GEN News Highlights

More »
Jan 4, 2008

WuXi PharmaTech to Acquire AppTec Laboratory Services for $151M

  • WuXi PharmaTech plans to buy AppTec Laboratory Services in a deal valued at $151 million. The acquisition adds biologics capabilities to WuXi PharmaTech’s services. The firm will also gain a significant U.S. operational footprint.

    It is expected that the combined business operations of WuXi PharmaTech and AppTec in the U.S. and China will enable WuXi PharmaTech to provide a full-service suite of outsourced chemistry and biology services to global pharmaceutical, biotechnology, and medical device clients.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?